Arcadia Biosciences | 8-K/A: Current report (Amendment)
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | DEFA14A: Others
Arcadia Biosciences | DEF 14A: Definitive information statements
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | 8-K: Current report
Arcadia Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Arcadia Biosciences | 8-K: Arcadia Biosciences (RKDA) Announces First Quarter 2023 Financial Results from Operations and Business Highlights
Arcadia Biosciences | DEFA14A: Others
Arcadia Biosciences | DEF 14A: Definitive proxy statements
No Data